Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thomssen

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Anti-Cancer Drugs|May 7, 2002
Trials of new combinations of Herceptin in metastatic breast cancerC Thomssen
Nature|August 22, 1991
High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3R Wank, C Thomssen
Zentralblatt Fur Gynakologie|October 22, 2003
[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast]N Harbeck, C Thomssen
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1988
The amniotic adhesion malformation complex associated with short or absent umbilical cordA Draeger, C Thomssen
Der Pathologe|March 26, 1999
[Algorithm of endometrial meta- and hyperplasia]T Löning, U Reusch, C Thomssen
Onkologie|November 8, 2003
Clinical relevance of prognostic factors in axillary node-negative breast cancerC Thomssen, F Jänicke, N Harbeck
Der Pathologe|March 26, 1999
[Algorithm of clinical aspects and pathology of endometrial carcinoma]T Löning, U Reusch, C Thomssen
Der Pathologe|March 26, 1999
[Diagnosis and therapy of cervical squamous epithelial carcinomas]L Riethdorf, T W Park, C Thomssen
Der Pathologe|August 25, 2012
[Intraoperative pathological rapid investigations in breast surgery]M Dämmrich, C Thomssen, P Hillemanns, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2021
Postmastectomy radiotherapy for all node positive patients: The case againstJ M Dixon, I H Kunkler, N Russell, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|May 7, 2002
Trials of new combinations of Herceptin in metastatic breast cancerC Thomssen
Nature|August 22, 1991
High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3R Wank, C Thomssen
Zentralblatt Fur Gynakologie|October 22, 2003
[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast]N Harbeck, C Thomssen
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1988
The amniotic adhesion malformation complex associated with short or absent umbilical cordA Draeger, C Thomssen
Der Pathologe|March 26, 1999
[Algorithm of endometrial meta- and hyperplasia]T Löning, U Reusch, C Thomssen
Onkologie|November 8, 2003
Clinical relevance of prognostic factors in axillary node-negative breast cancerC Thomssen, F Jänicke, N Harbeck
Der Pathologe|March 26, 1999
[Algorithm of clinical aspects and pathology of endometrial carcinoma]T Löning, U Reusch, C Thomssen
Der Pathologe|March 26, 1999
[Diagnosis and therapy of cervical squamous epithelial carcinomas]L Riethdorf, T W Park, C Thomssen
Der Pathologe|August 25, 2012
[Intraoperative pathological rapid investigations in breast surgery]M Dämmrich, C Thomssen, P Hillemanns, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2021
Postmastectomy radiotherapy for all node positive patients: The case againstJ M Dixon, I H Kunkler, N Russell, et al.
Pageof 8